Mirkka P Sarparanta (Mirkka Sarparanta)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 18

Top Venues

Molecular pharmaceutics

Bioconjugate chemistry

Molecules (Basel, Switzerland)

Advanced materials (Deerfield Beach, Fla.)

University of Helsinki

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Helsinki Sep 01 2014

Finland

Postdoctoral fellow :: Laboratory of Radiochemistry, Department of Chemistry

Memorial Sloan-Kettering Cancer Center Mar 01 2014 - Jul 31 2016

United States

Research fellow :: Department of Radiology

University of Helsinki Mar 01 2007 - Feb 15 2013

Finland

Doctoral student :: Laboratory of Radiochemistry, Department of Chemistry

Publications

Jelena Matović, Juulia Järvinen, Iris K Sokka, Surachet Imlimthan, Olli Aitio, Mirkka P Sarparanta, Jarkko Rautio, Filip S Ekholm
Towards New Delivery Agents for Boron Neutron Capture Therapy: Synthesis and In Vitro Evaluation of a Set of Fluorinated Carbohydrate Derivatives. Molecules (Basel, Switzerland) 29 (17) (2024)
Sofia Otaru, Tatu Martinmäki, Iida Kuurne, Andreas Paulus, Kerttuli Helariutta, Mirkka P Sarparanta, Anu J Airaksinen
Radiolabelling of peptides with tetrazine ligation based on the inverse electron-demand Diels-Alder reaction: rapid, catalyst-free and mild conversion of 1,4-dihydropyridazines to pyridazines. RSC advances 13 (32) (2023)
Jelena Matović, Katayun Bahrami, Philipp Stockmann, Iris K Sokka, You Cheng Khng, Mirkka P Sarparanta, Evamarie Hey-Hawkins, Jarkko Rautio, Filip S Ekholm
Sweet Battle of the Epimers─Continued Exploration of Monosaccharide-Derived Delivery Agents for Boron Neutron Capture Therapy. Molecular pharmaceutics (2023)
Sofia Otaru, Andreas Paulus, Surachet Imlimthan, Iida Kuurne, Helena Virtanen, Heidi Liljenbäck, Tuula Tolvanen, Tatsiana Auchynnikava, Anne Roivainen, Kerttuli Helariutta, Mirkka P Sarparanta, Anu J Airaksinen
Development of [ 18 F]AmBF 3 Tetrazine for Radiolabeling of Peptides: Preclinical Evaluation and PET Imaging of [ 18 F]AmBF 3 -PEG 7 -Tyr 3 -Octreotide in an AR42J Pancreatic Carcinoma Model. Bioconjugate chemistry 33 (7) (2022)
Jelena Matović, Juulia Järvinen, Iris K Sokka, Philipp Stockmann, Martin Kellert, Surachet Imlimthan, Mirkka P Sarparanta, Mikael P Johansson, Evamarie Hey-Hawkins, Jarkko Rautio, Filip S Ekholm
Synthesis and In Vitro Evaluation of a Set of 6-Deoxy-6-thio-carboranyl d-Glucoconjugates Shed Light on the Substrate Specificity of the GLUT1 Transporter. ACS omega 7 (34) (2022)
Dave Lumen, Danielle J Vugts, Marion Chomet, Surachet Imlimthan, Mirkka P Sarparanta, Ricardo Vos, Maxime Schreurs, Mariska Verlaan, Pauline A Lang, Eero Hippeläinen, Wissam Beaino, Albert D Windhorst, Anu J Airaksinen
Pretargeted PET Imaging with a TCO-Conjugated Anti-CD44v6 Chimeric mAb U36 and [ 89 Zr]Zr-DFO-PEG 5 -Tz. Bioconjugate chemistry 33 (5) (2022)
Elisavet Lambidis, Chun-Chieh Chen, Mo Baikoghli, Surachet Imlimthan, You Cheng Khng, Mirkka P Sarparanta, R Holland Cheng, Anu J Airaksinen
Development of 68 Ga-Labeled Hepatitis E Virus Nanoparticles for Targeted Drug Delivery and Diagnostics with PET. Molecular pharmaceutics 19 (8) (2022)
Surachet Imlimthan, You Cheng Khng, Outi M Keinänen, Wenzhong Zhang, Anu J Airaksinen, Mauri A Kostiainen, Brian M Zeglis, Hélder Almeida Santos, Mirkka P Sarparanta
A Theranostic Cellulose Nanocrystal-Based Drug Delivery System with Enhanced Retention in Pulmonary Metastasis of Melanoma. Small (Weinheim an der Bergstrasse, Germany) 17 (18) (2021)
Iris K Sokka, Surachet Imlimthan, Mirkka P Sarparanta, Hannu Maaheimo, Mikael P Johansson, Filip S Ekholm
Halogenation at the Phenylalanine Residue of Monomethyl Auristatin F Leads to a Favorable cis/trans Equilibrium and Retained Cytotoxicity. Molecular pharmaceutics 18 (8) (2021)
Jelena Matović, Juulia Järvinen, Iris K Sokka, Surachet Imlimthan, Jan-Erik Raitanen, Ahmed B Montaser, Hannu Maaheimo, Kristiina M Huttunen, Sirpa Peräniemi, Anu J Airaksinen, Mirkka P Sarparanta, Mikael P Johansson, Jarkko Rautio, Filip S Ekholm
Exploring the Biochemical Foundations of a Successful GLUT1-Targeting Strategy to BNCT: Chemical Synthesis and In Vitro Evaluation of the Entire Positional Isomer Library of ortho-Carboranylmethyl-Bearing Glucoconjugates. Molecular pharmaceutics 18 (1) (2020)
Sofia Otaru, Hanna Niemikoski, Mirkka P Sarparanta, Anu J Airaksinen
Metabolism of a Bioorthogonal PET Tracer Candidate [19F/18F]SiFA-Tetrazine in Mouse Liver Microsomes: Biotransformation Pathways and Defluorination Investigated by UHPLC-HRMS. Molecular pharmaceutics 17 (8) (2020)
Jelena Matović, Juulia Järvinen, Helena C Bland, Iris K Sokka, Surachet Imlimthan, Ruth Mateu Ferrando, Kristiina M Huttunen, Juri M Timonen, Sirpa Peräniemi, Olli Aitio, Anu J Airaksinen, Mirkka P Sarparanta, Mikael P Johansson, Jarkko Rautio, Filip S Ekholm
Addressing the Biochemical Foundations of a Glucose-Based "Trojan Horse"-Strategy to Boron Neutron Capture Therapy: From Chemical Synthesis to In Vitro Assessment. Molecular pharmaceutics 17 (10) (2020)
Sofia Otaru, Surachet Imlimthan, Mirkka P Sarparanta, Kerttuli Helariutta, Kristiina Wähälä, Anu J Airaksinen
Evaluation of Organo [18F]Fluorosilicon Tetrazine as a Prosthetic Group for the Synthesis of PET Radiotracers. Molecules (Basel, Switzerland) 25 (5) (2020)
Dave Lumen, Simo Näkki, Surachet Imlimthan, Elisavet Lambidis, Mirkka P Sarparanta, Wujun Xu, Vesa-Pekka Lehto, Anu J Airaksinen
Site-Specific 111In-Radiolabeling of Dual-PEGylated Porous Silicon Nanoparticles and Their In Vivo Evaluation in Murine 4T1 Breast Cancer Model. Pharmaceutics 11 (12) (2019)
Surachet Imlimthan, Alexandra Correia, Patrícia Figueiredo, Kalle Lintinen, Vimalkumar Balasubramanian, Anu J Airaksinen, Mauri A Kostiainen, Hélder Almeida Santos, Mirkka P Sarparanta
Systematic in vitro biocompatibility studies of multimodal cellulose nanocrystal and lignin nanoparticles. Journal of biomedical materials research. Part A 108 (3) (2019)
Surachet Imlimthan, Sofia Otaru, Outi Keinänen, Alexandra Correia, Kalle Lintinen, Hélder Almeida Santos, Anu J Airaksinen, Mauri A Kostiainen, Mirkka P Sarparanta
Radiolabeled Molecular Imaging Probes for the In Vivo Evaluation of Cellulose Nanocrystals for Biomedical Applications. Biomacromolecules 20 (2) (2018)
Didem Şen Karaman, Mirkka P Sarparanta, Jessica M Rosenholm, Anu J Airaksinen
Multimodality Imaging of Silica and Silicon Materials In Vivo. Advanced materials (Deerfield Beach, Fla.) 30 (24) (2018)
Outi Keinänen, Kimberly Fung, Jacob Pourat, Vilma Jallinoja, Delphine Vivier, NagaVara Kishore Pillarsetty, Anu J Airaksinen, Jason S Lewis, Brian M Zeglis, Mirkka P Sarparanta
Pretargeting of internalizing trastuzumab and cetuximab with a 18F-tetrazine tracer in xenograft models. EJNMMI research 7 (1) (2017)

Mirkka P Sarparanta.css-eqlu8i{font-size:small;padding-left:4px;} (Mirkka Sarparanta)

Publication Activity (10 Years)

Top Topics

Top Venues

Mirkka P Sarparanta (Mirkka Sarparanta)